Business description: Anbio Biotechnology

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Number of employees: 27

Other Medical Equipment, Supplies & Distribution

Change 5-day change 1-year change 3-year change Capi.($)
-6.03%-42.84%+77.98% - 721M
+0.27%-1.44%-33.86%-11.76% 155B
+0.01%-2.06%-8.87%-4.79% 103B
+0.98%+4.99%-0.98%+58.27% 54.72B
-0.23%-6.71%+50.66%+49.87% 53.65B
-0.98%-2.29%-15.39%-41.71% 40.72B
-0.51%+5.11% - - 30.9B
0.00%+3.35%-9.60%-40.89% 28.85B
-0.94%+3.38%+46.44%-8.21% 23.38B
-1.93%-0.66%-14.31%+2.17% 21.22B
Average -0.62%-1.91%+10.23%+0.37% 51.25B
Weighted average by Cap. -0.09%+2.23%-7.42%+1.08%
  1. Stock Market
  2. Stocks
  3. NNNN Stock
  4. Company Anbio Biotechnology
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!